NHS Introduces Enhanced Varenicline to Aid Smoking Cessation

The NHS is reintroducing the stop-smoking medication varenicline to help countless smokers in England quit cigarettes.

Varenicline, a prescription-only pill previously available as Champix, will serve as an alternative to nicotine gum, patches, and e-cigarettes.

It is proven to assist about one in four users in quitting smoking for at least six months, especially when combined with behavioural support.

This renewed availability could aid over 85,000 people annually in stopping smoking and potentially reduce 9,500 smoking-related deaths in the coming five years.

Around six million UK adults currently smoke, contributing to £2.5bn in healthcare costs yearly due to smoking-related illnesses.

Health Secretary Wes Streeting highlights potential NHS savings and speedier patient services.

Despite the efficacy of varenicline, some regions still lack adequate support services for smokers, a gap noted by Action on Smoking and Health CEO Hazel Cheeseman.

Professor Nick Hopkinson from Imperial College London endorses varenicline as a top smoking cessation aid, emphasizing the importance of combining medication with counselling.

Current local NHS services might also offer e-cigarettes in specific quit-smoking schemes, though these are not licensed as medicines.

The general advice remains to prioritize licensed smoking cessation medications.